Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Consolidated Net Income: 2019-2024

Historic Consolidated Net Income for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Dec 2024 value amounting to -$259.6 million.

  • Maravai Lifesciences Holdings' Consolidated Net Income rose 73.87% to -$45.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$213.8 million, marking a year-over-year increase of 33.91%. This contributed to the annual value of -$259.6 million for FY2024, which is 87.62% down from last year.
  • According to the latest figures from FY2024, Maravai Lifesciences Holdings' Consolidated Net Income is -$259.6 million, which was down 87.62% from -$138.4 million recorded in FY2023.
  • Over the past 5 years, Maravai Lifesciences Holdings' Consolidated Net Income peaked at $490.7 million during FY2022, and registered a low of -$259.6 million during FY2024.
  • For the 3-year period, Maravai Lifesciences Holdings' Consolidated Net Income averaged around $30.9 million, with its median value being -$138.4 million (2023).
  • Its Consolidated Net Income has fluctuated over the past 5 years, first spiked by 1,615.40% in 2020, then tumbled by 128.20% in 2023.
  • Maravai Lifesciences Holdings' Consolidated Net Income (Yearly) stood at $78.8 million in 2020, then spiked by 495.37% to $469.2 million in 2021, then grew by 4.56% to $490.7 million in 2022, then plummeted by 128.20% to -$138.4 million in 2023, then crashed by 87.62% to -$259.6 million in 2024.